Lessons from MATCH for future randomised trials in secondary prevention of stroke

Lancet. 2004 Jul;364(9431):305-7. doi: 10.1016/S0140-6736(04)16734-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Clopidogrel
  • Drug Therapy, Combination
  • Humans
  • Ischemic Attack, Transient / prevention & control
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Risk Factors
  • Stroke / prevention & control*
  • Ticlopidine / administration & dosage*
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin